Please login to the form below

Not currently logged in
Email:
Password:

Neovii Pharmaceuticals promotes Juergen Pohle to CEO

He will take over from Alexandre Sudarskis in January

Neovii Pharmaceuticals Juergen PohleSwiss biopharmaceutical company Neovii Pharmaceuticals has promoted its chief commercial officer Juergen Pohle to managing director and CEO.

He will assume the new role in January, when it takes over from outgoing CEO Alexandre Sudarskis who will continue at the firm as an executive director and member of its board.

David Fuhrer said: "Juergen's leadership skills, his long-term proven track record and his many years of international experience in the pharmaceutical industry make him the ideal candidate for the position of CEO.

“We are extremely pleased that Juergen has embraced the challenge of further driving the development and growth of Neovii."

Pohle has served as Neovii’s chief commercial officer of Pharmaceuticals since 2016 and has over 25 years of experience in the pharmaceutical industry, having previously worked at Bayer HealthCare, GlaxoSmithKline and Novartis.

Prior to joining Neovii he headed up Novartis’ emerging growth markets and institutional customers businesses.

18th September 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics